NeuroSense Therapeutics L... (NRSN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.02
-0.01 (-0.97%)
At close: Jan 15, 2025, 1:38 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
PE Ratio | -1.06 | -1.25 | -1.91 | -2.77 | -6.39 |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -5.71 | 2.50 | 0.53 | 11.90 | 8.54 |
P/FCF Ratio | -1.26 | -1.83 | -3.07 | -11.14 | -13.31 |
P/OCF Ratio | -1.27 | -1.85 | -3.1 | -11.28 | -13.47 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -0.08 | 0.04 | 0.20 | n/a | n/a |
Quick Ratio | 0.84 | 6.41 | 19.41 | 6.08 | 24.68 |
Current Ratio | 0.84 | 4.28 | 19.12 | 6.08 | 24.68 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -21.91 | -903.47 | -4.84 | -2.89K | -247 |
Return on Equity (ROE) | 5.39 | -1.99 | -0.28 | -4.29 | -1.34 |
Return on Assets (ROA) | -3.18 | -1.45 | -0.22 | -3.63 | -1.28 |
Return on Capital (ROIC) | 42.58 | -2.26 | -0.52 | -4.38 | -1.35 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |